MeritValue

EUDA Health Holdings Ltd

EUDAdata completeness 88%6 fiscal years on file

Data notes: no data for concept 'totalDebt'; no data for concept 'interestExpense'

i. The business — what you’d actually own
FigureFY 2022FY 2022FY 2023FY 2024FY 2025
Revenue—$3.76M1$3.71M2$4.01M2$6.82M2
Net income−$1.76M3−$24.9M4−$10M5−$15.4M5−$2.77M5
Operating cash flow−$1.01M6−$1.53M7−$2.92M8−$2.03M8−$2.43M8
Capital expenditure—$18,1379—$96,76210$77,26410
Free cash flow (derived)—−$1.54M7—−$2.13M8−$2.5M8
Total debt—————
Cash & equivalents$193,54611$57,54112$189,00512$237,60513$345,14413
Diluted shares2.4M12.0M1.1M1.6M1.9M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$22.78
your share of equity
Profit it earned you last year
−$14.85
Free cash flow it threw off
−$13.41
Debt you’d be carrying
—

10 shares is a claim on −$22.78 of net worth that earned you −$14.85 and generated −$13.41 of cash last year.

iii. Is this a good business?
Moat signal · return on equity
— avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
−24% shares · 5y

Share count is down 24% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 20-F/A · period ending 2022-12-31 · accession 0001493152-25-014808 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 20-F · period ending 2023-12-31 · accession 0001493152-26-019361 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 10-K · period ending 2022-07-31 · accession 0001493152-22-024263 (NetIncomeLoss)
  4. 20-F/A · period ending 2022-12-31 · accession 0001493152-25-014808 (NetIncomeLoss)
  5. 20-F · period ending 2023-12-31 · accession 0001493152-26-019361 (NetIncomeLoss)
  6. 10-K · period ending 2022-07-31 · accession 0001493152-22-024263 (NetCashProvidedByUsedInOperatingActivities)
  7. 20-F/A · period ending 2022-12-31 · accession 0001493152-25-014808 (NetCashProvidedByUsedInOperatingActivities)
  8. 20-F · period ending 2023-12-31 · accession 0001493152-26-019361 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K · period ending 2022-12-31 · accession 0001493152-23-022805 (PaymentsToAcquirePropertyPlantAndEquipment)
  10. 20-F · period ending 2024-12-31 · accession 0001493152-26-019361 (PaymentsToAcquirePropertyPlantAndEquipment)
  11. 10-K · period ending 2022-07-31 · accession 0001493152-22-024263 (CashAndCashEquivalentsAtCarryingValue)
  12. 20-F · period ending 2022-12-31 · accession 0001493152-24-018280 (CashAndCashEquivalentsAtCarryingValue)
  13. 20-F · period ending 2024-12-31 · accession 0001493152-26-019361 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)